Clinical Trial Update: 2-HOBA Supplementation in People With Elevated Lipoprotein(a) [NA]

View source ↗

Summary

A clinical trial is evaluating 2-HOBA supplementation for people with hyperlipidemia and elevated lipoprotein(a) and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Lipoprotein Elevation

Drugs mentioned

• 2-HOBA (2-HOBA (2-hydroxybenzylamine))

Snippet

Sponsor: The Miriam Hospital | Conditions: Hyperlipidemia, Elevated Lp(a) | NA | Status: NOT_YET_RECRUITING